Yasujima M, Abe K, Tanno M, Sato K, Kasai Y, Seino M, Chiba S, Goto T, Omata K, Tajima J
Clin Exp Hypertens A. 1984;6(7):1297-310. doi: 10.3109/10641968409039598.
To assess in vivo functional interactions of vasopressor substances, norepinephrine and vasopressin, with renal prostaglandins and kallikrein-kinin system which are responsible for the vasodepressor mechanism in the kidney, we evaluated chronic effects of norepinephrine (1.8 mg/kg/day ip) and vasopressin (7.2 U/kg/day ip) on urinary prostaglandin E excretion and urinary kallikrein excretion in conscious rats. Both norepinephrine and vasopressin induced a sustained increase in systolic blood pressure. Norepinephrine induced slight but significant increases in urinary prostaglandin E excretion and urinary kallikrein excretion which were sustained for up to 6 days. Vasopressin induced a marked increase in urinary prostaglandin E excretion which was sustained for up to 6 days, whereas it induced a sustained decrease in urinary kallikrein excretion. Circulating angiotensin II levels was not changed by norepinephrine, but was decreased by vasopressin. These results indicate that renal prostaglandin E may not correlate with renal kallikrein-kinin and renin-angiotensin system in the responses to norepinephrine and vasopressin, and that vasopressin may be a more potent stimulator of the synthesis or release of renal prostaglandin E.
为了评估升压物质去甲肾上腺素和血管加压素与肾前列腺素以及激肽释放酶-激肽系统在体内的功能相互作用,肾前列腺素和激肽释放酶-激肽系统负责肾脏的降压机制,我们评估了去甲肾上腺素(1.8毫克/千克/天,腹腔注射)和血管加压素(7.2单位/千克/天,腹腔注射)对清醒大鼠尿前列腺素E排泄和尿激肽释放酶排泄的慢性影响。去甲肾上腺素和血管加压素均导致收缩压持续升高。去甲肾上腺素使尿前列腺素E排泄和尿激肽释放酶排泄略有但显著增加,这种增加持续长达6天。血管加压素使尿前列腺素E排泄显著增加,持续长达6天,而它使尿激肽释放酶排泄持续减少。去甲肾上腺素未改变循环血管紧张素II水平,但血管加压素使其降低。这些结果表明,在对去甲肾上腺素和血管加压素的反应中,肾前列腺素E可能与肾激肽释放酶-激肽和肾素-血管紧张素系统无关,并且血管加压素可能是肾前列腺素E合成或释放的更强有力的刺激物。